Tocilizumab administration in a refractory case of COVID-19

Detalles Bibliográficos
Autores principales: Dastan, Farzaneh, Nadji, Seyed Alireza, Saffaei, Ali, Tabarsi, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264941/
https://www.ncbi.nlm.nih.gov/pubmed/32502524
http://dx.doi.org/10.1016/j.ijantimicag.2020.106043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264941/
https://www.ncbi.nlm.nih.gov/pubmed/32502524
http://dx.doi.org/10.1016/j.ijantimicag.2020.106043

Ejemplares similares